Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPT-80 vs Vancomycin in CDAD
NCT02179658Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2014
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fidaxomicin in Clostridioides difficile infection (CDI), sponsored by Astellas Pharma. Started Jun 2014; status: completed.
02
Drugs
fidaxomicin
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT02179658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02179658.